GDTC CytoMed Yalpi foyda bo'yicha rentabellik

CytoMed Therapeutics Limited (GDTC) korporativ emblemasi va logotipi

Biznesning yalpi foyda marjasi CytoMed Therapeutics (GDTC) kompaniyasining makroiqtisodiy tendentsiyalardan mustaqilligini ko'rsatadi, chunki onkologik terapiyaga bo'lgan talab sikllilikka bog'liq emas. Parametr qiymati -286.20 bo'lib, u kompaniyaning operatsion holatini aks ettiradi. O'sish potentsiali narxlarni belgilash imkoniyatini kafolatlovchi noyob donor T-hujayrali vaksinalariga asoslangan. Shu bilan birga, operatsiyalar biomateriallarni utilizatsiya qilish bo'yicha qat'iy tibbiy qoidalarga va back-office ekologik standartlariga tayanadi.

Yalpi marja: CytoMed Therapeutics (GDTC) 21.02.2024 - 20.11.2026 uchun

w2.cytomed.sg (GDTC) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Fundamental baholash:CytoMed Therapeutics (GDTC)
CytoMed Therapeutics tomonidan chiqariladigan mahsulotlar

CytoMed Therapeutics (GDTC) ning kredit sifatini baholash uchun tahlilchi yalpi foyda marjasini o'rganadi, u bevosita ishlab chiqarish xarajatlari chegirib tashlanganidan keyin qolgan daromad qismini o'lchaydi va bu bir martalik anomaliyalar tizimli tendentsiyadan ajratilishiga imkon beradi. CytoMed Therapeutics ning hamyonbop, universal T-hujayralarni joriy etish qobiliyati terapiya xarajatlarini kamaytiradi, bu esa ushbu ko'rsatkichning barqaror o'sishida aks etishi va kompaniyaning bozor ustunligini tasdiqlashi kerak.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi foyda bo'yicha rentabellik TCRX|Yalpi rentabellik CSBR|Yalpi marja XBIT|Yalpi foyda bo'yicha sotuv rentabelligi CEL-SCI Corp.|Yalpi rentabellik ostherapies.com OSTX|RADX: Sotuvning yalpi rentabelligi|ARTV: Yalpi foyda bo'yicha rentabellik|ANL (Adlai Nortye) - Sotuvning yalpi rentabelligi|Veru (VERU) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Tempest Therapeutics Inc|Yalpi rentabellik Xilio Therapeutics|Sotuvning yalpi rentabelligi RENB (Renovaro Inc.)|Yalpi rentabellik Mural Oncology PLC (MURA)|Yalpi marja Kairos Pharma (KAPA)|Yalpi rentabellik onkuretherapeutics.com OKUR|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik